Survival after lymph node dissection, radiotherapy, and combined treatment in sentinel node–positive stage IIIA Merkel cell carcinoma: A systematic review and meta-analysis
JAAD International · 2026-12 · 29 · 28-40
DOI: 10.1016/j.jdin.2026.06.025 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift JAAD International, 2026-12. Verfasst von Sophia Wasserer und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology and Allergy, School of Medicine, Technical University of Munich, Bavarian Cancer Research Center (BZKF), Munich, Germany. Die Arbeit nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Merkel cell carcinoma (MCC) has a high risk of regional lymphatic metastasis. In cases of lymphatic micrometastasis, an evidence-based clinical approach is missing.
Objective
To assess survival outcomes following complete lymph node dissection (CLND), radiation (RTX), or CLND plus RTX (CLND + RTX) in patients with stage IIIA MCC.
Methods
A systematic search was conducted in MEDLINE, Embase, and the Cochrane Library. Pooled survival rates were calculated using random-effects models. Comparative effectiveness of interventions was assessed via network meta-analysis.
Results
Eight studies, including 1825 patients, were analyzed. Pooled 1- and 3-year survival rates (overall survival and MCC-specific survival) following CLND (regardless of RTX) were 93% (95% CI, 89%-96%) and 71% (95% CI, 64%-77%), showing no significant difference compared with patients without CLND. Furthermore, relative risk ratios comparing RTX (regardless of CLND status) with no RTX demonstrated no significant differences for overall survival at either 1 or 3 years. Finally, a network meta-analysis also did not show superiority among CLND only, RTX only, and CLND + RTX in patients with stage IIIA MCC.
Limitations
The limited number of observational studies, data heterogeneity, missing data regarding immunotherapies, and low evidence levels according to the GRADE restrict definitive conclusions.
Conclusions
Findings underscore the need for large, prospective clinical trials to define optimal treatment strategies for patients with stage IIIA MCC. PROSPERO number: CRD42025636348.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Dermatology and Allergy, School of Medicine, Technical University of Munich, Bavarian Cancer Research Center (BZKF), Munich, Germany.
- Department of Dermatology and Allergy LMU University Hospital, LMU Medizin, LMU Munich, Bavarian Cancer Research Center (BZKF), Munich, Germany.
- Institute for Medical Information Processing, Biometry, and Epidemiology, Pettenkofer School of Public Health LMU Munich, Munich, Germany.
Zitieren
APA
Wasserer, S., Foerster, Y., Preis, S., Lauffer, F., Biedermann, T., Persa, O. D., & Mayer, K. E. (2026). Survival after lymph node dissection, radiotherapy, and combined treatment in sentinel node–positive stage IIIA Merkel cell carcinoma: A systematic review and meta-analysis. JAAD International, 29, 28-40. https://doi.org/10.1016/j.jdin.2026.06.025
Vancouver
Wasserer S, Foerster Y, Preis S, Lauffer F, Biedermann T, Persa OD, et al. Survival after lymph node dissection, radiotherapy, and combined treatment in sentinel node–positive stage IIIA Merkel cell carcinoma: A systematic review and meta-analysis. JAAD International. 2026;29:28-40. doi:10.1016/j.jdin.2026.06.025
BibTeX
@article{Wasserer2026,
author = {Wasserer, Sophia and Foerster, Yannick and Preis, Sarah and Lauffer, Felix and Biedermann, Tilo and Persa, Oana-Diana and Mayer, Kristine Elisabeth},
title = {Survival after lymph node dissection, radiotherapy, and combined treatment in sentinel node–positive stage IIIA Merkel cell carcinoma: A systematic review and meta-analysis},
journal = {JAAD International},
year = {2026},
volume = {29},
pages = {28--40},
doi = {10.1016/j.jdin.2026.06.025}
}
EUVIMED